ABCC2 (MRP2) is an important export pump, expressed at tissue barriers. The genetic variants À24C4T, 1249G4A and 3972C4T are leading to inter-individual differences of bioavailability of various endogenous and exogenous compounds. Considering ABCC2 haplotypes, we investigated DNA-protein binding properties, mRNA secondary structure, mRNA stability, protein expression and transport activity in various cell lines and analyzed the bioavailability of talinolol in 24 healthy Caucasian volunteers; À24C4T had no clear influence on DNA-protein binding and the mRNA stability did not differ significantly. In transfected HEK293T/17 cells, haplotypes H9 (CGT), H10 (TGC) and H12 (TGT) had significantly lower protein expression, whereas H2 (CAC) exhibited significantly increased protein expression compared to the wild type (H1, CGC): 32.7 ± 8.8, 73.1 ± 6.3; 44.0 ± 15.5 and 115.2±8.2%, respectively. This corresponded with efflux rates of the fluorescent dye glutathione-methylfluorescein in vitro and by trend with talinolol bioavailability in vivo. In conclusion our results show a haplotypedependent influence on transport capacity of ABCC2, which seems to be mainly based on posttranscriptional modification of protein expression rather than transport rates.
Introduction
The transmembrane transporter ABCC2 (MRP2, cMOAT) serves as an important efflux pump of endogenous and exogenous compounds. It is widely expressed at barriers of mammalian tissues such as liver, kidney and intestine and contributes significantly to the distribution and pharmacokinetics of a large number of substrates. Moreover, there is upcoming evidence that genetic variants can alter the function of ABCC2 possibly leading to clinically relevant changes of bioavailability of a wide range of drugs. 1 In vitro experiments but also in vivo studies showed that the 5 0 -UTR SNP À24C4T, which is strongly linked to the silent SNP 3972C4T, seems to be associated with a decreased function of the transporter; À24C4T reportedly lowers the clearance of mycophenolic acid in renal allograft recipients and methotrexate in pediatric acute lymphoblastic patients. [2] [3] [4] In non-cancerous renal cortex tissue À24C4T showed a significant decreased mRNA expression.
Non-small lung cancer patients exhibiting the variant allele showed a higher response to irinotecan therapy suggesting a higher bioavailability for this anti-neoplastic drug. 6 Moreover, hepatotoxicity of diclofenac and herbal remedies was associated with À24T. 7, 8 In vitro assays in HepG2 cells revealed a reduced reporter gene activity for the variant construct. 5, 7 Interestingly, Caucasian kidney transplant recipients (n ¼ 154) exhibited a significant higher allele frequency for the variant À24T allele than recently investigated healthy Caucasian controls (n ¼ 374) (35.4% vs 18.3%). 9, 10 The polymorphism 1249G4A that causes a valin to isoleucin exchange at position 417 in the ABCC2 protein is associated with an increased intestinal efflux and a significant decreased bioavailability of the b-blocker talinolol. 9 This is in line with the observation of a higher gastrointestinal toxicity of methotrexate in African Americans treated for rheumatoid arthritis. 11 The silent SNP 3972C4T was correlated with higher irinotecan bioavailability. 12 Rare ABCC2 variants such as 1446C4G, 3563T4A and 4544G4A were described to be associated with higher mRNA and protein expression in liver, respectively. 13, 14 Currently, it is not exactly known how and on which stage genetic variants interfere with the gene expression of ABCC2. Considering the full-length cDNA of ABCC2, we conducted different in vitro approaches to systematically follow the molecular effect of the most common SNPs (À24C4T, 1249G4A and 3972C4T) in Caucasians. As ABCC2 is subject of tissue-dependent differential regulation, the DNA-protein binding properties and mRNA degradation were investigated in liver adenocarcinoma-derived SK-Hep 1 cells and in kidney carcinoma A-498 cells, both heterozygote for ABCC2 À24C4T.
Furthermore, we aimed to elucidate the impact on mRNA secondary structure, transcription and translation efficiency as well as transport activity. On the basis of these results previously determined pharmacokinetic data of talinolol were re-analyzed. 9 To our knowledge this is the first comprehensive investigation to elucidate the molecular background of the genetically caused inter-individual differences of the function of ABCC2.
Materials and methods

Cell culture
Cells were cultured as follows: SK-Hep 1 (80% RPMI 1640, 20% fetal bovine serum (FBS)), A-498 (90% minimal essential medium eagle, 10% FBS), Caco-2 (80% minimal essential medium eagle, 20% FBS), HEK293T/17 (90% Dulbecco's modified eagle's medium 4.5 g l À1 glucose, 10% FBS) and MDCK II (90% Dulbecco's modified eagle's medium 1 g l À1 glucose, 10% FBS) at 37 1C and 5% CO 2 . All media were supplemented with 100 units ml À1 penicillin and 100 mg ml À1 streptomycin. Cell culture media and supplements were purchased from PAA (Pasching, Austria). HEK293T/17 and MDCK II cells were obtained from ATCC (Manassas, VA, USA), all other cell lines from DSMZ (Braunschweig, Germany).
Electro mobility shift assays
To elucidate the influence of ABCC2 À24C4T on putative DNA-protein binding properties, electrophoretic mobility shift assays were performed using the Gel Shift Assay System from Promega (Mannheim, Germany (Merck) . Immediately before lysis, 1 mM DTT (Amersham), protease inhibitor cocktail (complete mini, Roche, Mannheim, Germany) and phosphatase inhibitor cocktail (PhosSTOP, Roche) were added to each buffer. Binding reaction was carried out by incubating nuclear extracts (1 mg of protein), 2 ml of 5 Â binding buffer (Promega), 500 ng of polydeoxy (inosinate-cytidylate) acid sodium salt (Amersham) and 20 000 counts per minute of labeled oligonucleotide probes in presence and absence of unlabeled oligonucleotide probes as specific competitors in a total volume of 10 ml. After 30 min of incubation at 4 1C, samples were electrophoretically separated on a 4% polyacrylamide gel (acrylamide/bisacrylamide; 60:1; both purchased from Sigma). Autoradiograms were performed for 36 h. All electrophoretic mobility shift assays were conducted in two independent and identical experiments. Autoradiograms were analyzed by densitometry using the Quantity One 1-D Analysis Software 4.6.3 (Bio-Rad, Munich, Germany). The degree of the competition of the labeled À24C probe by unlabeled À24C or À24T probes is given as the ratio of band intensity of unlabeled À24 T to unlabeled À24C probe of respective concentrations (10-or 20-fold).
Genotyping
After isolation of DNA according to manufacture's instruction (DNeasy Tissue kit, Qiagen, Hilden, Germany) SK-Hep 1, A-498 and Caco-2 cells were genotyped for the polymorphisms À24C4T (rs717620), À23G4A (rs17216156), 1249G4A (V417I, rs2273697) and 3972C4T (I1324I, rs3740066) by pyrosequencing (PSQ) using the PSQ96HS system (Biotage, Uppsala, Sweden) following a standard protocol as described before. 9 Primers were created by the Assay Design software version 1.0 (Biotage). Sequences of primers are given in , Sigma) or vehicle (methanol, 1:4000). At different time points (0, 3, 6, 8, 24 , 30, 48 h) RNA was isolated (RNeasy Mini kit, Qiagen); 400 ng of total RNA using random hexamers and the Transcriptor First Strand cDNA Synthesis kit (Roche) were reversely transcribed. Allele-specific ABCC2 mRNA expression was determined by RT-PCR using the TaqMan technology (ABI Prism 7900 HT, Applied Biosystems, Darmstadt, Germany) and the absolute quantification method. cDNA-specific forward and reverse primer and two allele-specific fluorescent probes were established by PrimerExpress 3.0 Software (Applied Biosystems) listed in Table 1 . PCR fragments containing À24C or T flanked by the above mentioned primers were cloned into pDrive Cloning Vector (Qiagen PCR Cloning kit, Qiagen). These plasmids were aequimolar mixed and diluted from 10 7 to 10 3 copies per 2 ml and used for standard curves; 18S rRNA was used as internal reference. Standards for 18S rRNA were cloned from the PCR product obtained from the TaqMan Assay Hs99999901_s1 (Applied Biosystems). The PCR reaction was accomplished in a duplex run using Genotyping Master Mix (Applied Biosystems) and 900 nM of primers and 200 nM of each allele-specific probe in a total volume of 30 ml; 18S rRNA was measured by using Universal Master Mix and TaqMan Assay Hs99999901_s1 (Applied Biosystems). The thermocycler condition consisted of 2 min of incubation at 50 1C, 10 min of activation at 95 1C followed by 40 cycles of 15 s 95 1C and 1 min 60 1C. Two identical and independent experiments were performed. Each measurement was conducted in quadruplicates.
Cloning and characterization of ABCC2 haplotypes
To investigate the functional influence of ABCC2 polymorphisms representing the most common haplotypes in Caucasians PCR products containing human ABCC2 fulllength cDNA (NCBI accession number NM000392; 25 March 2007) linked to a flag-tag sequence (DYKDDDDK, DNA sequence indicated in bold) and a stop codon (indicated in italic) were generated using forward primer 5 0 -GAT CG*C TAG CGA TAA TTC CTG TTC CAC TTT CTT TGA TGA AAC AAG TAA AG and reverse primer 5 0 -TCC* CCG GGT CAC TTA TCG TCA TCG TCC TTA TAA TCG AAT TTT GTG CTG TTC ACA TTC TCA ATG CCA GCT TCC. The fragment was cloned between the NheI and XmaI restriction sites (indicated by an asterisk) of the expression vector pIRES2-ZsGreen1 (Takara Bio Europe/Clontech, Saint-Germain-enLaye, France). This vector permits the separate translation of recombinant ABCC2 and green fluorescence protein ZsGreen1 from a single bicistronic mRNA because of the internal ribosomal entry site (IRES) between ABCC2 and ZsGreen1. This tool allows on the one hand the exclusive detection of recombinant expressed ABCC2 in transfected cell lines by western blot analysis using the anti-Flag M2 antibody (Sigma). On the other hand, the detection of ZsGreen1 allows the determination of the transcription efficiency of recombinant ABCC2. Vector pDsRed2-C1 (Takara Bio Europe/Clontech) was co-transfected as internal control of transfection efficiency. Gene point mutations were introduced into the wild-type ABCC2 vector construct according to the most common ABCC2 haplotypes having a 
Impact of ABCC2 haplotypes on gene regulation and function S Laechelt et al frequency 410% (see Table 2 ) using the QuikChange II XL site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). H10 was additionally cloned to exclusively test for the functional impact of À24C4T.
Transient transfection HEK293T/17 cells and MDCK II cells were seeded in six-well plates at a density of 2 Â 10 5 cells per ml. After 24 h HEK293T/17 cells were transiently transfected with pIRES2-ZsGreen1 vector constructs containing ABCC2 haplotypes (H1: À24C/1249G/3972C; H2: CAC; H9: CGT; H10: TGC and H12: TGT) or pIRES2-ZsGreen1 vector without insert as negative control (1.6 mg per well) and pDsRed2-C1 (marker of transfection efficiency) (0.4 mg per well) using FuGENE HD (Roche). MDCK II cells were transfected with ABCC2 vector constructs (3.2 mg per well) and pDsRed2-C1 (0.8 mg per well) using Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. Transfected cells were incubated for 48 h under cell culture conditions. Subsequently, proteins were isolated for western blot analysis. Transfections were performed using four independently generated DNA preparations of each vector construct. For the analysis of recombinant ABCC2 protein expression in HEK293T/17 cells seven identical and independent experiments were performed.
Immunfluorescence HEK293T/17 cells were transiently transfected with pIRES2-ZsGreen1 vector constructs containing ABCC2 haplotypes as described above. Transfected cells were incubated for 48 h under cell culture conditions. Subsequently, cells were fixed using 4% paraformaldehyde in PBS buffer (PAA). After permeabilizing the cells with methanol the blocking was performed using 5% FCS in PBT buffer (PBS þ 0.1% Triton X-100). The primary antibody anti-Flag M2 (dilution: 1:300; Sigma) was incubated over night at 4 1C. Alexa Fluor 568 goat anti-mouse IgG (dilution 1:600; Invitrogen) was used as secondary antibody. The nuclei were stained using Immunoselect Antifading Mounting Medium DAPI (Dianova, Hamburg, Germany). Documentations were carried out using Zeiss Axio Imager Z1 and AxioVision-Program v4.5 (Zeiss, Hamburg, Germany).
Western blot analysis
Proteins were isolated using mammalian cell lysis buffer including protease inhibitors (Qiagen) and quantified using Bio-Rad Protein Assay (Bio-Rad). After separation on Nu-PAGE Novex 10% Bis-Tris Gels (Invitrogen) proteins were transferred to polyvinylidene fluoride microporous membranes (Millipore, Schwalbach, Germany) using a tank blotting system (Bio-Rad). Membranes were blocked in 5% (w/v) non-fat dried milk in TBS-T buffer (0.27 mM KCl, 13.7 mM NaCl, 5 mM Tris-HCl, pH 7.4, 0.1% (w/v) Tween 20) and incubated overnight with the primary antibodies antiFlag M2 (dilution: 1:1000; Sigma), MRP2 M 2 III-6 (dilution 1:500; Alexis, San Diego, CA, USA), DsRed (dilution 1:1000; Takara Bio Europe/Clontech), ZsGreen (dilution 1:1000; Takara Bio Europe/Clontech) and anti-b-actin as internal standard (dilution: 1:10 000; Sigma). Horseradish peroxidase-labeled rabbit anti-mouse IgG (dilution: 1:10 000; Sigma) and goat anti-rabbit IgG (dilution 1:10 000; Santa Cruz, Heidelberg, Germany) were used as secondary antibodies. Detection was accomplished by chemiluminescence with ECL Western Blotting Detection Reagents (GE Healthcare, Munich, Germany). Blots were analyzed by densitometry using the Quantity One 1-D Analysis Software 4.6.3 (Bio-Rad). Data were normalized to b-actin as internal standard. Normalized DsRed was used as marker of transfection efficiency.
Transport assay
For measurement of ABCC2 haplotype-dependent efflux, MDCK II cells exhibiting a low endogenous transport activity were used. Cells were transfected with the ABCC2 haplotype vector constructs and cultured for 48 h. After removing the medium, cells were incubated in Hanks 
Mann-Whitney U-test; variant haplotypes vs wild type; n ¼ 4.
The variant alleles are indicated in bold.
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Balanced Salt Solution (supplemented with 10 mM HEPES, pH 7.5) including 2.5 mM 5-chloromethylfluoresceindiacetate (CMFDA) (CellTracker Green CMFDA, Invitrogen) at culture conditions. CMFDA permeates the cell membrane and is intracellularly metabolized to fluorescent glutathione-methylfluorescein, a substrate of ABCC2. Glutathione-methylfluorescein efflux from cells was determined by removing supernatant in 100 ml aliquots (n ¼ 8) after 30, 60 and 90 min and fluorescence was measured using a Fluoroskan Ascent (Thermo Fisher, Langenselbold, Germany) and filters at 485 nm for excitation and at 518 nm for emission. Subsequently, proteins were isolated for western blot analysis as described above and transport activity was normalized to protein expression of transfected ABCC2 haplotype constructs. Four independent experiments were conducted.
In vivo pharmacokinetics of talinolol
To elucidate the influence of the most common ABCC2 haplotypes, we re-analyzed a previously published study on the pharmacokinetics of Talinolol. In this study, a subset of 31 out of 374 healthy Caucasian volunteers received intravenously and orally 30 and 100 mg talinolol (Cordanum; Arzneimittelwerk Dresden, Dresden, Germany), respectively. 9 Twenty-four of those (15 males, 9 females, aged 19-35 years, body weight 49-99 kg) exhibiting at least one of the investigated haplotypes H1, H2, H9 and H12 were again examined. All subjects had given their written informed consent and the study was approved by the ethics committee of the University of Greifswald.
Statistical analysis
Differences in protein expression, transport activity and talinolol kinetics of wild type compared with variant haplotypes were compared by Mann-Whitney U-tests performed by using SPSS 17.0. A P-valuep0.05 was considered to be statistically significant. Half-lives of different mRNA species were calculated by 0.693/k. The decay constant k was obtained after semi-logarithmic scaling by slope x (À2.303).
Results
Impact of ABCC2 À24C4T polymorphism on DNA-protein binding activity
To elucidate whether the À24C4T polymorphism alters DNA-protein binding properties in the ABCC2 5 0 -UTR, two double-stranded [ 
Impact of ABCC2 À24C4T polymorphism on mRNA degradation
The investigated cell lines (SK-Hep 1, A-498 and Caco-2) had different ABCC2 diplotypes allowing determination of the mRNA degradation of different haplotypes. All had the wild type for the rare SNP À23G4A, but SK-Hep 1 cells exhibited the diplotype H2/H12, A-498 cells the diplotype H1/H12 and Caco-2 cells the diplotype H1/H9 (for haplotype nomenclature see Table 2 ). Using allele-specific quantitative RT-PCR, the ABCC2 haplotype mRNA degradation was determined in SK-Hep 1 and A-498 cells being heterozygous for À24C4T. The specificity of the assay was beforehand determined in Caco-2 cells being homozygote for À24C (specificity of probes was 495%). The overall mRNA degradation time was similar in SK-Hep 1 as well as in A-498 cells (Figure 2) . In SK-Hep 1 cells, the mean half-lives of haplotypes H2 and H12 mRNA were 15.6 and 13.0 h, respectively. In A-498 cells, the half-lives of H1 and H12 mRNA were 10.8 and 11.6 h. To normalize to unequal distribution of alleles on DNA level in these carcinomaderived cell lines the expression of mRNA haplotype species were compared with vehicle.
mRNA secondary structure Using mfold web server, 15 the mRNA secondary structures of ABCC2 haplotypes were calculated (Figure 3) . The wild type exhibited the highest enthalpy at 37 1C (À5939 kJ mol À1 ), Impact of ABCC2 haplotypes on gene regulation and function S Laechelt et al whereas haplotype H12, consisting of À24T/3972 T was calculated to have the lowest (À6033 kJ mol À1 ) ( Table 2) .
Influence of ABCC2 haplotypes on protein expression
To investigate the protein expression of ABCC2 haplotypes, HEK293T/17 cells were transiently transfected with pIRES2-ZsGreen1 vector constructs containing the respective ABCC2 haplotype and pDsRed2-C1 vector as internal control of transfection efficiency. Three haplotypes H9 (À24C/1249G/3972 T), H10 (-24T/1249G/3972C) and H12 (À24T/1249G/3972 T) were associated with significantly decreased protein expression compared with H1 (wild type) (32.7 ± 8.8%; P ¼ 0.001, 73.1 ± 6.3%; P ¼ 0.001 and 44.0 ± 15.5%; P ¼ 0.001, respectively). In contrast, H2 (À24C/1249A/3972C) exhibited a significantly increased protein expression (115.2±8.2%; P ¼ 0.017) (Figure 4) .
Immunfluorescence experiments revealed for all ABCC2 haplotypes proper expression and processing of ABCC2 protein on the cell surface ( Figure 5 ).
Influence of ABCC2 haplotypes on transcription and translation
In pIRES2-ZsGreen1 vector constructs, the gene sequence of ZsGreen1 is located downstream of ABCC2 cDNA, separated by an IRES. Therefore, a bicistronic mRNA is transcribed, allowing the synchronously determination of transcriptional and posttranscriptional effects on the protein formation of different ABCC2 haplotypes. In four independent and identical experiments, recombinant ABCC2 and ZsGreen1 protein expressions were determined in transiently transfected HEK293T/17 cells. In contrast to recombinant ABCC2 protein expression, the ZsGreen1 protein expression did not differ significantly between the different ABCC2 haplotypes: H2 (94.3 ± 19.3%, P ¼ 1.0), H9 (94.7 ± 7.4%, P ¼ 0.22), H10 (102.3 ± 16.2%, P ¼ 1.0) and H12 (98.4±19.2%, P ¼ 1.0) (Figure 4 ).
Transport activity of ABCC2 haplotypes
To examine the functional influence of ABCC2 haplotypes, we conducted an efflux assay in transfected MDCK II cells using CMFDA. First, it was proven that all cells transiently transfected with constructs containing the ABCC2 gene exhibited higher efflux rates than cells transfected with constructs lacking the insert (data not shown), indicating functional activity of the cloned ABCC2 haplotypes. Second, haplotypes H9 and H12 showing lower protein expressions had significantly decreased efflux rates, whereas H10 did not show a significant difference in transport activity ( Figure 6 ; Table 2 ). In line with higher protein expression in vitro, H2 exhibited a significantly increased transport activity (30 and 90 min). Accordingly, after normalization to the respective protein expression in MDCK II cells, the differences in transport activities were diminished (data not shown). These results suggest that haplotype-dependent transport is mainly caused by different protein expression.
Bioavailability of talinolol in vivo
The bioavailability and AUC oral of talinolol were analyzed in 24 volunteers exhibiting at least one of the investigated haplotypes (H10 was not present in any volunteer). No significant differences of any ABCC2 diplotype could be detected. However, analogue to the haplotype-dependent protein expression of our in vitro experiments, ABCC2 haplotype H2 (only SNP 1249G4A) seems to decrease, whereas H9 (only SNP 3972C4T) and H12 (À24C4T and 3972C4T) increased the bioavailability and AUC oral of talinolol ( Figure 7 ).
Discussion
In our study, we aimed to clarify the molecular background of upcoming evidence from in vitro and in vivo studies that polymorphisms influence the function of the ABCC2 transporter. Major results were a higher protein expression and transport activity of the ABCC2 haplotype H2 and lower In a systematic approach we tried to elucidate the molecular background of these observations on DNAprotein binding properties, mRNA secondary structure, mRNA degradation, transcription and translation efficiency as well as transport activity.
After investigating the impact of the ABCC2 5 0 -UTR À24C4T SNP on DNA-protein interactions by electro mobility shift assays, we could observe no significant difference in kidney carcinoma-derived A-498 cells and in liver adenocarcinoma-derived SK-Hep 1 cells. Moreover, we could not observe different haplotype-dependent ABCC2 mRNA degradation in SK-Hep 1 as well as in A-498 cells. After genotyping using the methodology of PSQ we could observe an unequal allele distribution in the investigated cell lines, probably caused by a partly loss of heterozygosity. By combining the peak ratios at the polymorphisms À24C4T, 1249G4A and 3972C4T it was possible to define exact haplotype pairs. However, the unequal allele distribution is a limitation to compare directly the absolute expression of ABCC2 mRNA species combined in a diplotype.
To answer the question whether the different ABCC2 haplotypes would have different translational activity because of altered mRNA structure, we performed in silico analysis revealing five different ABCC2 mRNA secondary structures for the haplotypes investigated. Assuming that haplotypes having lower enthalpies are thermodynamically more stable than those with higher enthalpies, it could be hypothesized that a greater energetically effort is required to disentangle the mRNA for ribosome migration leading to lower translation efficacy, as could be shown for haplotypes of the human catechol-O-methyltransferase. 16 Thus, H1, H2 and H9 were expected to have higher translation rates than H10 and H12 and this was at least in line with the observation of a higher protein expression of H1 and H2 compared with H10 and H12. H9, however, revealed the weakest protein expression in the western blot.
The relative synonymous codon usage is a further parameter that is believed to be involved in translation kinetics, based on the proportionality of codon frequency and cellular amount of respective tRNA. 17, 18 Such a phenomenon is discussed for the functional meaning of the ABCB1 (P-glycoprotein) 3435C4T SNP. 17, 18 Similar conditions could be suggested at position 3972 where a C4T exchange leads to the exchange of triplet codon for isoleucin from AUC to AUU. Finally, protein expression can be influenced through the conformation of the translation machinery at the 5 0 -cap of the mRNA affected by the 5 0 -UTR SNP À24C4T. 19 Similar to observations in intestine, 9 we could confirm a lower ABCC2 protein expression in vitro for haplotype H10, being variant for À24C4T, but the effect on glutathione-methylfluorescein efflux was weak and there was no carrier of H10 in the in vivo assay using talinolol as substrate. The limitation of our in vitro approach of conducting electrophoretic Impact of ABCC2 haplotypes on gene regulation and function S Laechelt et al mobility shift assay using nuclear extracts of cancer cell lines cannot completely clarify the genotype-dependent differences in mRNA expression in non-tumorous cortical kidney tissue as described earlier. However, in renal cell cancer tissue we also could not find a significant difference of À24C4T on ABCC2 mRNA expression. 5 Moreover, the findings of this study enlarge the understanding of the previously described reporter gene assay. Usually, reporter gene assays are conducted to investigate the influence of polymorphisms on promoter activity. Owing to the close localization to the start codon the À24C4T polymorphism is not only located on the DNA sequence but it is also located on the 5 0 -UTR of the mRNA of the reporter gene. Therefore, we cannot distinguish on which level the polymorphism affects gene expression. On the other hand, we cannot exclude two independent effects of À24C4T on transcriptional and posttranscriptional level. Our in vitro findings of a lower protein expression for the 3972 T containing haplotypes H9 and H12 are supported by recent in vivo studies showing a higher risk for intrahepatic cholestasis in pregnancy for 3972 T carriers 20 and a higher susceptibility for cholangiocarcinoma probably because of a higher bioavailability of environmental carcinogens. 21 The impact of the haplotypes on ABCC2 protein expression was clearly mirrored in the transport rates of the fluorescent dye glutathione-methylfluorescein, indicating that the protein expression rather than transport activity altered the efflux rates. This is in line with findings of Hirouchi et al. 22 showing no differences in transport activity after normalization on protein expression at least concerning the 1249G4A polymorphism.
Moreover, theses findings are subsidized by the re-analysis of talinolol pharmacokinetic in healthy volunteers. 9 In this study, we observed by trend an increased bioavailability of the b1-selective adrenoreceptor antagonist talinolol in carriers of haplotypes H9 and H12, both containing 3972 T. In contrast, haplotype H2, being variant at 1249G4A and associated with increased protein expression in vitro, consequently led to decreased bioavailability of talinolol because of increased efflux transport into the intestine.
A limitation of the in vivo study on talinolol is the fact that there were only a very small number of individuals homozygous for defined haplotypes. To further elucidate the impact of ABCC2 haplotypes in vivo, it appears worthwhile to reconfirm our results prospectively in an increased population size of carriers of defined ABCC2 diplotypes using not only exogenous but also endogenous ABCC2 substrates.
Moreover, it should be clarified, whether ABCC2 haplotype-dependent mRNA secondary structures can influence the efficiency of microRNAs as posttranscriptional gene silencer contributing to the observed posttranscriptional influence of genetic variants on ABCC2 protein expression. Further, the molecular mechanisms behind the low protein expression of haplotype H9 (exclusively 3972 T) should be elucidated.
In conclusion, our results show a clear haplotypedepended influence on transport capacity of ABCC2, which are based probably on a posttranscriptional modification of protein expression rather than transport activities. These results could help to better understand the impact of ABCC2 variants on the pharmacokinetics of a number of drugs, considering defined haplotypes.
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